 |
Michael Santoro, PhDExclusive Representation
Keynote Fee : $10,001 - $15,000 plus expenses Fee Note Travels From: NY |
Topics
- Ethics / Values
- Leadership
Formats
- Keynote
Products
* Click on the Product to Order
Programs
Ethics and the Pharmaceutical IndustryDespite the pharmaceutical industry's notable contributions to human progress, including the development of miracle drugs for treating cancer, AIDS, and heart disease, there is a growing tension between the industry and the public. Debates are raging over how the industry can and should be expected to act. In this program, Dr. Santoro highlights the opposing forces underlying the tension between the need for financial incentives for drug discovery and the global need for affordable medicines.
He provides provocative, yet balanced, perspectives from leaders of industry, government, ethics, business and the medical community. Dr. Santoro examines such aspects from physician professionalism and research integrity to drug pricing, direct-to-consumer advertising, and intellectual property rights.
Speaker Information
Michael Santoro is Associate Professor with tenure at Rutgers Business School, where he teaches courses on business ethics, multinational corporations and global social issues, labor and human rights, international law, and ethical issues in the pharmaceutical industry. He has lectured and published widely on these topics.
Dr. Santoro is the author of Profits and Principles: Global Capitalism and Human Rights in China (2000) and his most recent book: Ethics In the Pharmaceutical Industry (2005) co-written with Thomas Gorrie Corporate VP at Johnson & Johnson. He has also published numerous journal articles, op-ed articles, and book chapters on these topics in publications such as Foreign Policy and Human Rights Quarterly.
Dr. Santoro's past business experiences include being the general counsel of one of the first publicly held biotechnology companies. He was also the director and the legal advisor to a software company formed by experts in mathematical optimization. Dr. Santoro helped to formulate the company's product development and market entry strategy in the logistics and enterprise management space. He also helped to secure various stages of financing for the company which was eventually acquired at a significant multiple by a publicly held company.
He holds a Ph.D. in Public Policy from Harvard University, a J.D. from the New York University School of Law and an A.B. from Oberlin College. He is also a Fulbright Fellow at the University of Hong Kong. As a Research Associate at Harvard Business School, he wrote or co-authored nearly thirty case studies and teaching notes on ethical and legal topics such as global protection of intellectual property, insider trading, the Federal Sentencing Guidelines and Fair Credit Reporting Act.
Testimonials
"Dr. Santoro provides thoughtful dialogue from diverse viewpoints on some of the most significant issues in health care-we need this kind of meaningful dialogue to happen more often."
- Tommy G. Thompson, Former Secretary of Health & Human Services